2024 JP Morgan Healthcare Conference slide image

2024 JP Morgan Healthcare Conference

BRUKER AN EMERGING LEADER OF THE POST-GENOMIC ERA Enabling Post-Genomic Era Research, Drug Discovery and Diagnostics 2022 Bruker >25% Revenue Mix 2023 Bruker Post-Genomic Life-Science Tools and Diagnostics >$650M revenue p.a. Virtuous Cycle, enabling technology: high-performance instruments, automation, consumables and software unlock post-genomic biology for research, better Dx and better drug discovery & development MALDI Biotyper" sirius MALDI Biotyper Microbiology Crystallography Structural Biology tims TOFlex tims TOFⓇ 4D-Proteomics 4D-Multiomics CelScope BRUKER GHz-NMR Functional Structural Biology Ascend 1.2GHz Innovation with Integrity | canopy CellScape Spatial Biology January 8, 2024 I 23
View entire presentation